Despite a revenue decline, 23andMe Holding Co (ME) focuses on cost-saving measures and recurring revenue growth to enhance financial stability.

Anne Wojcicki; Chairman of the Board, President, Chief Executive Officer, Co-Founder; 23andMe Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer; 23andMe Holding ...

On Tuesday, direct-to-consumer genetic testing firm 23andMe announced it would be shuttering its much-hyped drug development ...

The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company ...

The company had 40 million monthly active users on ad plans in May. It finished the third quarter with a total of 282.7 ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

23andMe's CEO called the decision to lay off 200 employees "difficult but necessary." 23andMe has laid off 40% of its employees as the company undergoes restructuring. They have also discontinued the ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

In the wake of a big data breach and a sizable new round of layoffs, concerns about the 23andMe's handling of sensitive ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...